Recent News

Symposium’23 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30
Program here.
3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
Programme ici, inscriptions ici, .
FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
FairEmbo en Afrique : l’Embolisation-pour-tous franchit une nouvelle étape. Plus d’informations ici.
Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
Plus d’informations ici.
Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Plus d’informations sur le prix AP-HM de l’innovation 2022 ici. Plus d’informations sur le projet Embobio dans cette vidéo.
CERIMED OBTAINS DUAL ISO 9001:2015 AND NF X50-900:2016 CERTIFICATION FOR ITS PRE-CLINICAL RADIOLOGICAL AND NUCLEAR SERVICE AND INNOVATION ACTIVITIES
On June 5, 2022, the European Center for Research in Medical Imaging (CERIMED, UMS AMU CNRS 2012) obtained dual ISO 9001:2015 and NF-X50-900 certification for its pre-clinical
Symposium’21 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”
Program here.
VECT-HORUS and CERIMED Announce Collaboration to Support the Development of VECT-HORUS’ Theragnostic Agents
VECT-HORUS, a biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, has announced the signing of a collaboration
FAIR-Embo hopes to spread safe, cheap embolization around the world
We are proud to anounce that Pr Vincent Vidal (Marseille, France), Head of the Experimental Interventional Radiology Laboratory hosted at CERIMED, and colleagues have demonstrated the in vivo feasibility

Last Publications (10/462)

Louis, B, Roussel, T, Cruz-Dubois, T, Ding, L, Lyu, Z, Laurini, E et al.. Fluorinated Amphiphilic Dendrimer to Improve PET Imaging of Cancer. Small. 2026; :e11972. doi: 10.1002/smll.202511972. PubMed PMID:42084057 .
Goga, A, Soussi, G, Mogenet, A, Habert, P, Fourdrain, A, Naud, R et al.. Single-center retrospective cohort study of lung cancer associated with interstitial lung disease: Prognostic factors and molecular profile. Lung Cancer. 2026;215 :109379. doi: 10.1016/j.lungcan.2026.109379. PubMed PMID:41887129 .
Duong, QH, Le, TK, Tran, TT, Audebert, S, Camoin, L, Nguyen, NG et al.. HSP27 functional switch drives castration-resistant prostate cancer via mTOR pathway activation, highlighting promising combination therapies. J Exp Clin Cancer Res. 2026;45 (1):. doi: 10.1186/s13046-026-03695-6. PubMed PMID:41877198 PubMed Central PMC13085302.
Cherrak, C, Guerra, X, Panneau, J, Vidal, V, Golzarian, J, Dariane, C et al.. Prostatic artery embolization for benign prostatic hyperplasia: State of the art. Diagn Interv Imaging. 2026; :. doi: 10.1016/j.diii.2026.03.002. PubMed PMID:41866253 .
Maisons, V, Nassar, N, Cottier, JP, Barbet, C, Sautenet, B, Mercier, E et al.. Reversible cerebral lesions in adult STEC-associated hemolytic uremic syndrome. Kidney Int. 2026;109 (4):798. doi: 10.1016/j.kint.2025.08.047. PubMed PMID:41864670 .
Baboudjian, M, Sordelli, F, Patard, JJ, Moussi, B, Graffeille, V, Basset, V et al.. Targeted and Perilesional or Systematic Biopsies in Prostate Cancer: The TARGET Clinical Trial Protocol. Eur Urol Oncol. 2026; :. doi: 10.1016/j.euo.2026.02.003. PubMed PMID:41813528 .
Pin, G, Horowitz, T, Guedj, E, Felician, O, Ceccaldi, M, Koric, L et al.. Isolated medial temporal lobe amnesia (MTLA): Predictor of cerebral amyloidosis or marker of phenotype-specific vulnerability?. Rev Neurol (Paris). 2026;182 (4):290-300. doi: 10.1016/j.neurol.2026.02.149. PubMed PMID:41775642 .
Ruimy, A, Agripnidis, T, Panneau, J, Nguyen, J, Tradi, F, Marx, T et al.. A New Generation of Eco-Designed Embolic Agents: Towards Sustainable and Personalized Interventional Radiology. J Pers Med. 2026;16 (2):. doi: 10.3390/jpm16020064. PubMed PMID:41745357 PubMed Central PMC12941600.
Ranque, S, Laurin, J, Linguraru, MG, Jiang, Z, Loundou, A, Boyer, L et al.. Efficacy and mechanism of supervised adapted physical activity on quality of life for patients with fibromyalgia: single-center, prospective, randomised clinical and neuroimaging study. Sci Rep. 2026;16 (1):5398. doi: 10.1038/s41598-025-33433-5. PubMed PMID:41634061 PubMed Central PMC12886965.
Gargiulo, M, Di-Rocco, C, Bartoli, A, Habert, P, Soussan, J, Barral, PA et al.. Embolic agents in emergency care: a large retrospective cohort study. CVIR Endovasc. 2026;9 (1):13. doi: 10.1186/s42155-026-00651-5. PubMed PMID:41632442 PubMed Central PMC12868507.

Search PubMed

Dernières Publications (10/462)

Louis, B, Roussel, T, Cruz-Dubois, T, Ding, L, Lyu, Z, Laurini, E et al.. Fluorinated Amphiphilic Dendrimer to Improve PET Imaging of Cancer. Small. 2026; :e11972. doi: 10.1002/smll.202511972. PubMed PMID:42084057 .
Goga, A, Soussi, G, Mogenet, A, Habert, P, Fourdrain, A, Naud, R et al.. Single-center retrospective cohort study of lung cancer associated with interstitial lung disease: Prognostic factors and molecular profile. Lung Cancer. 2026;215 :109379. doi: 10.1016/j.lungcan.2026.109379. PubMed PMID:41887129 .
Duong, QH, Le, TK, Tran, TT, Audebert, S, Camoin, L, Nguyen, NG et al.. HSP27 functional switch drives castration-resistant prostate cancer via mTOR pathway activation, highlighting promising combination therapies. J Exp Clin Cancer Res. 2026;45 (1):. doi: 10.1186/s13046-026-03695-6. PubMed PMID:41877198 PubMed Central PMC13085302.
Cherrak, C, Guerra, X, Panneau, J, Vidal, V, Golzarian, J, Dariane, C et al.. Prostatic artery embolization for benign prostatic hyperplasia: State of the art. Diagn Interv Imaging. 2026; :. doi: 10.1016/j.diii.2026.03.002. PubMed PMID:41866253 .
Maisons, V, Nassar, N, Cottier, JP, Barbet, C, Sautenet, B, Mercier, E et al.. Reversible cerebral lesions in adult STEC-associated hemolytic uremic syndrome. Kidney Int. 2026;109 (4):798. doi: 10.1016/j.kint.2025.08.047. PubMed PMID:41864670 .
Baboudjian, M, Sordelli, F, Patard, JJ, Moussi, B, Graffeille, V, Basset, V et al.. Targeted and Perilesional or Systematic Biopsies in Prostate Cancer: The TARGET Clinical Trial Protocol. Eur Urol Oncol. 2026; :. doi: 10.1016/j.euo.2026.02.003. PubMed PMID:41813528 .
Pin, G, Horowitz, T, Guedj, E, Felician, O, Ceccaldi, M, Koric, L et al.. Isolated medial temporal lobe amnesia (MTLA): Predictor of cerebral amyloidosis or marker of phenotype-specific vulnerability?. Rev Neurol (Paris). 2026;182 (4):290-300. doi: 10.1016/j.neurol.2026.02.149. PubMed PMID:41775642 .
Ruimy, A, Agripnidis, T, Panneau, J, Nguyen, J, Tradi, F, Marx, T et al.. A New Generation of Eco-Designed Embolic Agents: Towards Sustainable and Personalized Interventional Radiology. J Pers Med. 2026;16 (2):. doi: 10.3390/jpm16020064. PubMed PMID:41745357 PubMed Central PMC12941600.
Ranque, S, Laurin, J, Linguraru, MG, Jiang, Z, Loundou, A, Boyer, L et al.. Efficacy and mechanism of supervised adapted physical activity on quality of life for patients with fibromyalgia: single-center, prospective, randomised clinical and neuroimaging study. Sci Rep. 2026;16 (1):5398. doi: 10.1038/s41598-025-33433-5. PubMed PMID:41634061 PubMed Central PMC12886965.
Gargiulo, M, Di-Rocco, C, Bartoli, A, Habert, P, Soussan, J, Barral, PA et al.. Embolic agents in emergency care: a large retrospective cohort study. CVIR Endovasc. 2026;9 (1):13. doi: 10.1186/s42155-026-00651-5. PubMed PMID:41632442 PubMed Central PMC12868507.

Search PubMed